Search research articles
Contact Us
Filters
Showing results (11-20 of 93) with videos related to
Page
of 10
Sort By:
Journal of Hepatology
|
November 1, 2020
Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"
Dong Ji, Gregory Cheng, George Lau
Hepatology (Baltimore, Md.)
|
September 17, 2025
Reply: Insights into immune-mediated adverse events and survival outcomes: Lessons from HIMALAYA
Ghassan K Abou-Alfa, George Lau
Global Health & Medicine
|
November 16, 2021
Achieving WHO target of HCV control in Hong Kong: challenges and strategies
Yudong Wang, Gregory Cheng, George Lau
Hepatology International
|
August 12, 2009
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies
George Lau, Patrick Marcellin, Marion Peters
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 28, 2016
Reply
Cheng Wang, Guofeng Chen, George Lau
Journal of Hepatology
|
May 22, 2020
Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'
Dong Ji, Enqiang Qin, George Lau
Journal of Hepatology
|
May 15, 2020
Reply to: 'NAFLD or comorbidities, that is the question'
Dong Ji, Dawei Zhang, George Lau
Hepatology (Baltimore, Md.)
|
October 29, 2017
Reply
Guo-Feng Chen, Cheng Wang, George Lau
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 5, 2017
Treatment of chronic hepatitis B infection-2017
Guo-Feng Chen, Cheng Wang, George Lau
Journal of Cataract and Refractive Surgery
|
April 20, 2023
Safety and effectiveness comparison of a new cohesive ophthalmic viscosurgical device
Mark Packer, Mitchell Shultz, James Loden, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 93) with videos related to
Sort By:
Page
of 10
Journal of Hepatology
|
November 1, 2020
Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"
Dong Ji, Gregory Cheng, George Lau
Hepatology (Baltimore, Md.)
|
September 17, 2025
Reply: Insights into immune-mediated adverse events and survival outcomes: Lessons from HIMALAYA
Ghassan K Abou-Alfa, George Lau
Global Health & Medicine
|
November 16, 2021
Achieving WHO target of HCV control in Hong Kong: challenges and strategies
Yudong Wang, Gregory Cheng, George Lau
Hepatology International
|
August 12, 2009
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies
George Lau, Patrick Marcellin, Marion Peters
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 28, 2016
Reply
Cheng Wang, Guofeng Chen, George Lau
Journal of Hepatology
|
May 22, 2020
Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'
Dong Ji, Enqiang Qin, George Lau
Journal of Hepatology
|
May 15, 2020
Reply to: 'NAFLD or comorbidities, that is the question'
Dong Ji, Dawei Zhang, George Lau
Hepatology (Baltimore, Md.)
|
October 29, 2017
Reply
Guo-Feng Chen, Cheng Wang, George Lau
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 5, 2017
Treatment of chronic hepatitis B infection-2017
Guo-Feng Chen, Cheng Wang, George Lau
Journal of Cataract and Refractive Surgery
|
April 20, 2023
Safety and effectiveness comparison of a new cohesive ophthalmic viscosurgical device
Mark Packer, Mitchell Shultz, James Loden, et al.
Page
of 10